Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-12-21

Clinical Trial Update: Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity? [NA]

View source ↗

Summary

A clinical trial is exploring whether aspirin could protect against hearing loss caused by chemotherapy (chemotherapy-induced ototoxicity).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hearing Loss, Ototoxicity | NA | Status: UNKNOWN